Mesenchymal Stem Cells for The Treatment of Frailty Syndrome

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions

Frailty Syndrome

Interventions

BIOLOGICAL

UMC119-06-05

Cohort 1: Low does of UMC119-06-05 Cohort 2: High does of UMC119-06-05

Trial Locations (1)

RECRUITING

Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City